Marker Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.

About MRKR

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX. 

CEO
Peter L. Hoang
CEOPeter L. Hoang
Employees
56
Employees56
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
1991
Founded1991
Employees
56
Employees56

MRKR Key Statistics

Market cap
26.85M
Market cap26.85M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
284.40K
Average volume284.40K
High today
$0.3264
High today$0.3264
Low today
$0.2901
Low today$0.2901
Open price
$0.2972
Open price$0.2972
Volume
47.86K
Volume47.86K
52 Week high
$1.26
52 Week high$1.26
52 Week low
$0.25
52 Week low$0.25

MRKR Earnings

-$0.16
-$0.11
-$0.05
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 15, After Hours
ActualExpected Feb 15, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.